Cargando…
Mechanisms of Colorectal Cancer Prevention by Aspirin—A Literature Review and Perspective on the Role of COX-Dependent and -Independent Pathways
Aspirin, synthesized and marketed in 1897 by Bayer, is one of the most widely used drugs in the world. It has a well-recognized role in decreasing inflammation, pain and fever, and in the prevention of thrombotic cardiovascular diseases. Its anti-inflammatory and cardio-protective actions have been...
Autores principales: | Sankaranarayanan, Ranjini, Kumar, D. Ramesh, Altinoz, Meric A., Bhat, G. Jayarama |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729916/ https://www.ncbi.nlm.nih.gov/pubmed/33260951 http://dx.doi.org/10.3390/ijms21239018 |
Ejemplares similares
-
Do Aspirin and Flavonoids Prevent Cancer through a Common Mechanism Involving Hydroxybenzoic Acids?—The Metabolite Hypothesis
por: Sankaranarayanan, Ranjini, et al.
Publicado: (2020) -
Aspirin metabolites 2,3-DHBA and 2,5-DHBA inhibit cancer cell growth: Implications in colorectal cancer prevention
por: Sankaranarayanan, Ranjini, et al.
Publicado: (2020) -
Salicylic acid metabolites and derivatives inhibit CDK activity: Novel insights into aspirin's chemopreventive effects against colorectal cancer
por: Dachineni, Rakesh, et al.
Publicado: (2017) -
The Flavonoid Metabolite 2,4,6-Trihydroxybenzoic Acid Is a CDK Inhibitor and an Anti-Proliferative Agent: A Potential Role in Cancer Prevention
por: Sankaranarayanan, Ranjini, et al.
Publicado: (2019) -
Aspirin inhibits glucose-6-phosphate dehydrogenase activity in HCT 116 cells through acetylation: Identification of aspirin-acetylated sites
por: Ai, Guoqiang, et al.
Publicado: (2016)